Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Recruiting · NCT07217678 · Registry updated 2026-03-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 4 | 2026-03-05 | NCT07217678 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| University of Miami | 277 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bascom Palmer Eye Institute | Miami | United States | 1 |